Table 3.
Demographic comparison of participants who completed the study and participants who withdrew prior to 20-week data collection
| Completers (n = 92) | Dropouts (n = 41) | P-value | |||
|---|---|---|---|---|---|
| Characteristic | N | % | N | % | |
| Study group | 0.009* | ||||
| -Intervention | 45 | 48.9 | 30 | 73.2 | |
| -Control | 47 | 51.1 | 11 | 26.8 | |
| Age, years, Mean (SD) | 57.0 (12.0) | 57.1 (12.1) | 0.960 | ||
| Female gender | 72 | 78.3 | 31 | 75.6 | 0.736 |
| Married/de facto | 67 | 72.8 | 26 | 65.0 | 0.365 |
| Completed post-school qualifications | 64 | 69.6 | 31 | 79.5 | 0.245 |
| Employed (full-time or part-time) | 40 | 43.5 | 17 | 43.6 | 0.991 |
| Weekly family income | 0.178 | ||||
| -Less than $499 | 12 | 13.2 | 11 | 27.5 | |
| -$500–$1000 | 24 | 26.4 | 6 | 15.0 | |
| -More than $1000 | 28 | 30.8 | 11 | 27.5 | |
| -Prefer not to answer | 27 | 29.7 | 12 | 30.0 | |
| Number of co-morbidities (ever or current) | 0.073 | ||||
| -0 | 24 | 26.1 | 5 | 12.2 | |
| -1 or more | 68 | 73.9 | 36 | 87.8 | |
| Types of co-morbiditiesa | |||||
| -Musculoskeletal disorders | 33 | 36.3 | 15 | 38.5 | 0.834 |
| -Mental health problems | 25 | 27.5 | 17 | 43.6 | 0.086 |
| -Arthritis | 29 | 31.9 | 21 | 53.8 | 0.028* |
| -High blood pressure | 24 | 26.4 | 12 | 30.8 | 0.608 |
| -High cholesterol | 33 | 36.3 | 11 | 28.2 | 0.396 |
| Cancer survivor status | 0.535 | ||||
| -Cancer survivor | 65 | 70.7 | 31 | 77.5 | |
| -Carer | 19 | 20.7 | 5 | 12.5 | |
| -Both cancer survivor and carer | 8 | 8.7 | 4 | 10.0 | |
| Relationship to cancer survivor: | |||||
| -Spouse/partner | 17 | 63.0 | 6 | 66.7 | 0.397 |
| Cancer typea | |||||
| -Breast | 47 | 64.4 | 17 | 48.6 | 0.118 |
| -Prostate | 8 | 11.0 | 6 | 17.1 | 0.375 |
| -Other: colorectal, melanoma, non-Hodgkins lymphoma, Leukaemia, ovarian, thyroid, lung. | 17 | 23.2 | 7 | 20.0 | |
| Time since diagnosis, months, Mean (SD) | 38.0 (43.5) or 3.2 years | 50.1 (72.3) or 4.2 years | 0.293 | ||
| Ever received the following cancer treatmentsa | |||||
| -Surgery | 69 | 94.5 | 31 | 91.2 | 0.677 |
| -Chemotherapy | 49 | 71.0 | 24 | 82.8 | 0.431 |
| -Radiotherapy | 42 | 64.6 | 20 | 69.0 | 0.759 |
| -Hormone treatment | 35 | 70.0 | 15 | 62.5 | 0.632 |
| Cancer in remission | 54 | 77.1 | 26 | 81.3 | 0.356 |
| BMI category (kg/m2) | 0.468 | ||||
| -Less than 25 | 31 | 34.4 | 16 | 43.2 | |
| -25–30 | 36 | 40.0 | 14 | 37.8 | |
| -30 and above | 23 | 25.6 | 7 | 18.9 | |
*denotes significant difference (P < 0.05)
aParticipants could select more than one response, so the percentage may add up to more than 100 %